Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Alerts
    4. Historic national takedown of 345 defendants shows telemedicine is ripe for government enforcement

      Alerts

    Alert / Healthcare

    Historic national takedown of 345 defendants shows telemedicine is ripe for government enforcement

    Oct 7, 2020

    LinkedInX (Twitter)EmailCopy URL

    By Rebecca Simone, Jill Gordon, Brian French, Harsh Parikh, Valerie Montague and Laurie Cohen

    While telemedicine continues to be at the forefront of our evolving health care system, it is susceptible to fraud opportunities. We highlight what health service providers need to know about current enforcement efforts and the importance of a sound compliance program.

    DOWNLOAD

    PDF: Telemedicine enforcement

    Last week, the U.S. Department of Health and Human Services, Office of Inspector General (OIG), along with its state and federal law enforcement partners, announced a national telemedicine health care fraud takedown, involving 345 defendants in 51 judicial districts, including telemedicine executives, the owners of durable medical equipment (DME) companies, genetic-testing laboratories, pharmacies, and more than 100 medical practitioners. According to the government, the action involved $6 billion in alleged loss to federal health care programs. The historical national takedown uncovered over $4.5 billion in allegedly false and fraudulent claims concerning telemedicine.

    A common telemedicine model that the government continues to scrutinize, and was included in this recent takedown, is one where a telemedicine company connects physicians to patients for consultations. The “consultations” consist of either telephone calls or simple reviews of electronic questionnaires. The consultation results in a transmission of a prescription for a drug, device, diagnostic test, or piece of equipment that is reimbursed by Medicare, Medicaid, or another payor. Often times, this telemedicine model involves aggressive direct marketing to Medicare beneficiaries, advertising items to improve discomfort, such as medications or braces, or direct-to-consumer access to diagnostic tests, all paid by insurance. While ordering drugs, tests, DME, and other items via telemedicine may be compliant if carefully structured; the government has alleged, in several instances, that a telemedicine provider and/or supplier (such as DME supplier, laboratory, or pharmacy) paid illegal kickbacks and bribes to physicians to order items for Medicare beneficiaries that were medically unnecessary and, therefore, not reimbursable by the Medicare program. Additionally, the OIG fact sheet on this most recent takedown describes the proceeds of the alleged fraudulent scheme as being laundered through international shell corporations and foreign banks. The OIG posted the following diagram of the latest scheme, which it considers the largest takedown of health care fraud in the OIG’s history.

    telemedicine-enforcement-07Oct2020

    The acceptance and use of telemedicine grew exponentially after third-party payers, including Medicare Advantage, Medicare, state Medicaid programs, and commercial plans, began covering health care services delivered via telemedicine. This acceptance was spurred by the novel coronavirus (COVID-19) pandemic, which is fundamentally transforming telemedicine in the American health care system. Over the past few months, telemedicine technology made it possible for patients to receive medical services and care from the safety of their homes or other alternative care settings. As addressed in prior client alerts, there have been numerous federal and state waivers, exceptions, and executive orders enacted to ease regulatory restrictions, enabling both providers and patients to provide/receive virtual care without being overburdened with meeting technical legal requirements. We have also seen a steady increase in government enforcement actions surrounding telemedicine with the increased use and reimbursement for these services.

    While telemedicine continues to be at the forefront of our evolving health care system, it is susceptible to fraud opportunities because of the absence of direct patient contact and/or any prior professional relationship between the patient and the ordering telemedicine provider. This recent enforcement action is a reminder to health care providers, suppliers, and telemedicine companies to ensure that any proposed telemedicine business model is carefully vetted and launched in compliance with both state and federal law.

    Practices

    Government Investigations & White Collar DefenseState Attorneys GeneralHealthcareDigital Health & TelemedicineHealthcare Dispute ResolutionHealthcare Regulatory & ComplianceMedicare, Medicaid, and Other Government Payors

    Industries

    Healthcare

    Insights And Happenings

    • Alert

      DEA proposes regulations for prescribing controlled substances via telemedicine

      March 2, 2023
    • Alert

      Under Biden administration, and a Democratic Congress, SEC investigations likely to increase

      Feb 16, 2021
    • Press Release

      Nixon Peabody establishes State Attorneys General practice team

      Jan 28, 2021
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved